Published in J Clin Invest on April 01, 1993
Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am (2007) 2.17
Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat Rev Rheumatol (2014) 1.24
Eosinophils and disease pathogenesis. Semin Hematol (2012) 1.05
Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis. PLoS One (2014) 0.98
Eosinophilic granulomatosis with polyangiitis: an overview. Front Immunol (2014) 0.95
Sudden death of a patient with primary hypereosinophilia, colon tumours, and pulmonary emboli. J Clin Pathol (2004) 0.93
Therapeutic approaches to patients with hypereosinophilic syndromes. Semin Hematol (2012) 0.92
Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation. J Intensive Care (2015) 0.91
Spectrum of Eosinophilic End-Organ Manifestations. Immunol Allergy Clin North Am (2015) 0.89
A case of hypereosinophilic syndrome presenting with multiorgan infarctions associated with disseminated intravascular coagulation. Allergy Asthma Immunol Res (2011) 0.82
Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev (2013) 0.80
Increased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice. Am J Pathol (2004) 0.80
Control of hypereosinophilic syndrome-associated recalcitrant coronary artery spasm by combined treatment with prednisone, imatinib mesylate and hydroxyurea. Exp Clin Cardiol (2006) 0.78
The relationship between eosinophilia and slow coronary flow. Ther Clin Risk Manag (2015) 0.78
Prognostic Value of Eosinophil to Leukocyte Ratio in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. J Atheroscler Thromb (2016) 0.75
Renal involvement in idiopathic hypereosinophic syndrome. Clin Kidney J (2013) 0.75
Pleural mesothelioma and venous thrombosis: the eosinophilia link. Thromb J (2008) 0.75
Hypereosinophilia with multiple thromboembolic cerebral infarcts and focal intracerebral hemorrhage. Korean J Radiol (2009) 0.75
Renal thrombotic microangiopathy and FIP1L1/PDGFRα-associated myeloproliferative variant of hypereosinophilic syndrome. Clin Kidney J (2013) 0.75
Evaluation of plasma eosinophil count and mean platelet volume in patients with coronary slow flow. Clinics (Sao Paulo) (2014) 0.75
The Relationship Between Plasma Eosinophil Count and Coronary Artery Ectasia. Cardiol Res (2013) 0.75
Eosinophils in Autoimmune Diseases. Front Immunol (2017) 0.75
Loeffler's syndrome. Pediatr Cardiol (2010) 0.75
Bee and wasp venoms. Science (1972) 7.35
Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med (1986) 6.32
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med (1982) 4.70
The eosinophilic leukocyte: structure and function. Adv Immunol (1986) 4.08
Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci U S A (1981) 3.88
Raised serum levels of tumour necrosis factor in parasitic infections. Lancet (1986) 3.23
The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem (1989) 3.14
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science (1990) 3.02
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med (1979) 2.86
Protamine is an inhibitor of angiogenesis. Nature (1982) 2.30
Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy. Clin Exp Immunol (1976) 2.10
Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet (1987) 1.98
Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest (1976) 1.96
Structure and function of thrombomodulin: a natural anticoagulant. Blood (1990) 1.96
Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol (1985) 1.92
Eosinophilia and heart disease. Br Heart J (1977) 1.90
Using linear and non-linear regression to fit biochemical data. Trends Biochem Sci (1990) 1.89
Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J Exp Med (1989) 1.83
Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol (1986) 1.65
Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood (1989) 1.64
Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J Exp Med (1974) 1.61
Modulation of intracellular potassium and ATP: effects on coated pit function in fibroblasts and hepatocytes. J Cell Physiol (1985) 1.53
Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med (1990) 1.48
Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest (1981) 1.46
Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol (1988) 1.44
The active site of thrombin is altered upon binding to thrombomodulin. Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation. J Biol Chem (1991) 1.44
Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol (1983) 1.36
The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells. J Biol Chem (1988) 1.34
Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res (1979) 1.30
Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J Biol Chem (1990) 1.30
Activation of platelets by eosinophil granule proteins. J Exp Med (1990) 1.29
Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein. J Biol Chem (1988) 1.25
Further localization of binding sites for thrombin and protein C in human thrombomodulin. J Biol Chem (1990) 1.09
Presence and function of chondroitin-4-sulfate on recombinant human soluble thrombomodulin. Biochem Biophys Res Commun (1990) 1.08
Pulmonary carcinoma with eosinophilia. Demonstration of a tumor-derived eosinophilopoietic factor. N Engl J Med (1983) 1.00
Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan. J Biol Chem (1990) 0.97
Relationship between anticoagulant activities and polyanionic properties of rabbit thrombomodulin. J Biol Chem (1988) 0.97
Functional domains of rabbit thrombomodulin. Proc Natl Acad Sci U S A (1986) 0.96
Bromide-dependent toxicity of eosinophil peroxidase for endothelium and isolated working rat hearts: a model for eosinophilic endocarditis. J Exp Med (1991) 0.94
Proteolytic formation and properties of functional domains of thrombomodulin. J Biol Chem (1987) 0.93
A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem (1989) 0.93
Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism. Biochemistry (1987) 0.89
Domain structure of the endothelial cell receptor thrombomodulin as deduced from modulation of its anticoagulant functions. Evidence for a glycosaminoglycan-dependent secondary binding site for thrombin. J Biol Chem (1990) 0.86
Recombinant human thrombomodulin. Regulation of cofactor activity and anticoagulant function by a glycosaminoglycan side chain. Biochem J (1992) 0.83
Preparation of thrombomodulin from human placenta. Thromb Res (1985) 0.83
Relationship between post-translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulin. Br J Haematol (1991) 0.83
Decreased thrombin affinity of cell-surface thrombomodulin following treatment of cultured endothelial cells with beta-D-xyloside. Biochem Biophys Res Commun (1990) 0.81
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (1994) 8.73
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev (1997) 5.65
Guidelines for the management of hemophilia. Haemophilia (2012) 5.16
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci (2000) 4.14
The eosinophilic leukocyte: structure and function. Adv Immunol (1986) 4.08
Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest (1992) 3.50
Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res (1988) 3.47
Measurement of IgE in normal and allergic serum by radioimmunoassay. J Lab Clin Med (1971) 3.47
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis (1988) 3.45
Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev (1992) 3.42
Cytotoxic properties of the eosinophil major basic protein. J Immunol (1979) 3.29
Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int (2001) 3.07
An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med (1990) 3.05
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet (1994) 3.05
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet (1996) 2.93
Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis (1993) 2.83
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol (1979) 2.81
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med (1998) 2.80
Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A (1993) 2.77
Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest (1980) 2.70
Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis (1995) 2.65
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin Proc (1992) 2.64
Measuring circulating cell-derived microparticles. J Thromb Haemost (2004) 2.61
Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med (1984) 2.52
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood (1993) 2.48
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40
Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol (1997) 2.35
The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol (1986) 2.29
A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25
Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy. Transfusion (1996) 2.22
Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet (1982) 2.21
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost (2010) 2.12
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood (2000) 2.10
Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis (1989) 2.08
Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am J Pathol (1985) 2.08
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med (1990) 2.06
Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med (1990) 2.05
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Inter-neonatal intensive care unit variation in discharge timing: influence of apnea and feeding management. Pediatrics (2001) 1.98
Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet (1987) 1.98
Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest (1976) 1.96
The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A (1999) 1.90
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med (1998) 1.90
Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med (1973) 1.87
Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A (1981) 1.85
Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc (1981) 1.85
Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2001) 1.84
Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J Exp Med (1989) 1.83
IgA-induced eosinophil degranulation. J Immunol (1989) 1.82
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med (1990) 1.80
Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med (1985) 1.79
Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. Mayo Clin Proc (1997) 1.78
Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med (1991) 1.77
Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest (1991) 1.77
Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med (1988) 1.75
Production of human immunoglobulin E antibody in vitro. J Immunol (1979) 1.73
Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur J Immunol (1991) 1.71
Eosinophils 1992. Immunol Today (1992) 1.69
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69
Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest (1991) 1.68
Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A (1986) 1.67
Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation (1999) 1.66
Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol (1986) 1.65
Reperfusion injury pathophysiology in sickle transgenic mice. Blood (2000) 1.65
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol (1989) 1.64
Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis. Genes Immun (2006) 1.64
Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ (1999) 1.63
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62
Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J Exp Med (1974) 1.61
In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J Exp Med (1997) 1.61
Selective stimulation and purification of eosinophils and neutrophils from guinea pig peritoneal fluids. J Lab Clin Med (1973) 1.61
Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol (1991) 1.60
Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function. Curr Cancer Drug Targets (2010) 1.60
Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest (1991) 1.60
Eosinophil infiltration and degranulation in normal human tissue. Anat Rec (1998) 1.59
Role of TCR zeta chain in T cell development and selection. Science (1994) 1.59
Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest (1998) 1.58
Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med (1994) 1.58
Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol (1992) 1.58
Taurocholate transport by rat liver sinusoidal membrane vesicles: evidence of sodium cotransport. Hepatology (1982) 1.57
A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials (2005) 1.57
Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity (1997) 1.56
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology (1999) 1.54
Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost (2013) 1.53
The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol (1982) 1.53
Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. Int J Radiat Oncol Biol Phys (2001) 1.53
Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest (1993) 1.53
Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clin Exp Allergy (1993) 1.52
Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am Rev Respir Dis (1988) 1.52
Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol (1997) 1.52
Rat liver canalicular membrane vesicles. Isolation and topological characterization. J Biol Chem (1983) 1.51